QA: Longboard Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001832168_2023_Longboard_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001832168, Longboard Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 69,838,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,000
3 remainder_Assets 769,000
4 LiabilitiesCurrent 8,764,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,160,000
9 ResearchAndDevelopmentExpense 34,638,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 853,000
13 remainder_ComprehensiveNetIncome -528,000
  yvar yval
0 Assets 70,616,000
1 Liabilities 8,764,000
2 Expenses 44,798,000
3 Revenues 0
4 StockholdersEquity 61,852,000
5 NetIncome -43,945,000
6 ComprehensiveNetIncome -44,209,000
7 BaseVar 62,779,500
8 EconomicCapitalRatio 1.57

Edgar->Model Mapping

Feature Distribution

Change over Time